Status:
COMPLETED
The "PC-LIGHT" Study
Lead Sponsor:
Northwestern University
Conditions:
Prostate Cancer
Sleep
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Fatigue due to cancer and its treatment (for example, radiation therapy) can interfere with quality of life and can linger long after treatment has ended, yet research examining preventative approache...
Eligibility Criteria
Inclusion
- Have been diagnosed with clinical localized prostate cancer,
- Are about to begin external beam radiation therapy (RT) for prostate cancer,
- Are 18 years of age or older,
- Are able to speak or read English,
- Have internet access.
Exclusion
- History of light therapy use (e.g. systematic light exposure),
- Active infection
- History of chronic fatigue disorders
- Confounding underlying medical illnesses such as significant pre-existing anemia (Hb\<10 gm/dl)
- Diagnosed or suspected psychiatric or medical condition that might contribute to fatigue (other than those caused by the cancer or its treatment)
- Hypothyroidism or documented history of hypothyroidism on thyroid replacement hormone within \<3 months of initiating RT
- History of bipolar disorder or mania
- History of seasonal affective disorder
- Diagnosed sleep apnea, restless legs, or other sleep disorders (not including insomnia) known to affect fatigue
- Use of photosensitizing medication
- Plans to travel across more than 2 time zones during the study
- Shift worker
- Adults unable to consent, individuals who are not yet adults, pregnant women, and prisoners will be excluded from the study
Key Trial Info
Start Date :
December 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03419585
Start Date
December 12 2018
End Date
December 31 2023
Last Update
March 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Univeristy Feinberg School of Medicine
Chicago, Illinois, United States, 60611